Concepedia

Publication | Closed Access

ROLE OF ADDITIONAL DEXAMETHASONE FOR THE MANAGEMENT OF PERSISTENT OR RECURRENT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDER RANIBIZUMAB TREATMENT

DOI

22

Citations

22

References

2016

Year

Sandra Rezar‐Dreindl, Katharina Eibenberger, Wolf Buehl, Michael Georgopoulos, Guenther Weigert, Christoph Krall, Roman Dunavoelgyi, Ursula Schmidt‐Erfurth, Stefan Sacu
Retina

Abstract

This pilot study indicates combined therapy to delay retreatment in patients with persistent/recurrent neovascular age-related macular degeneration and an overall reduction in required ranibizumab retreatments compared with ranibizumab monotherapy with consistent functional outcomes.

References

YearCitations

Page 1